Doctors say growing 'toolbox' of coronavirus treatments provide bright spot in pandemic fight


There's no COVID-19 cure yet, but health care workers can still count many tiny victories that are making the fight easier.
In the early days of the coronavirus pandemic, doctors "were flying blind" as they tried to treat a disease with mysterious symptoms and very little research, Jose Pascual, a critical care doctor at the University of Pennsylvania Health System, tells The Washington Post. But health care workers everywhere have since "devised a toolbox, albeit a limited and imperfect one, of drugs and therapies" they believe are improving patients' chances of survival every day, the Post reports.
When Penn Medicine hospitals first started receiving coronavirus patients, they were ready to focus on patients' lungs, so they stockpiled ventilators and trained workers to treat breathing complications, Pascual told the Post. Yet coronavirus patients soon started throwing doctors "curveballs" in the form of kidney, liver, skin, and brain complications, Pascual described. Doctors around the country also noted how seemingly healthy patients could actually have "abnormally low oxygen levels," the Post writes.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
But those shocking developments quickly became lessons. Hospitals started quickly measuring oxygen levels in any suspected coronavirus patients, and learned how to boost breathing support for patients. They knew to look for unexpected side effects in other parts of the body. And after some once-promising drugs proved unhelpful in the coronavirus fight, doctors have been able to rule them out in favor of more effective drugs.
Of course, there's still no definitive cure or even treatment regimen for COVID-19. Doctors are all using experimental approaches that will have to be further researched through randomized clinical trials before they're approved for general use. Read more at The Washington Post.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia